Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Hanson

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|December 1, 1989
Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1K P Anderson, C Lucas, C V Hanson, et al.
Journal of Virology|May 1, 1990
Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animalsS Sutjipto, N C Pedersen, C J Miller, et al.
Asian Pacific Journal of Allergy and Immunology|June 1, 1997
International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, ChinaD Li, B D Forrest, Z Li, et al.
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Prevalence of HTLV-I/II among blood bank donors in ArgentinaM B Bouzas, G R Muchinik, I Zapiola, et al.
The Journal of Infectious Diseases|February 1, 1992
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopesJ J Lipka, I Miyoshi, K G Hadlock, et al.
Asian Pacific Journal of Allergy and Immunology|March 1, 1997
International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, ThailandP Phanuphak, S Teeratakulpixarn, S Sarangbin, et al.
The Journal of Infectious Diseases|August 1, 1991
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and IIJ J Lipka, P Santiago, L Chan, et al.
The Journal of Infectious Diseases|August 1, 1990
Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type IJ J Lipka, K Bui, G R Reyes, et al.
The Journal of Infectious Diseases|February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M C Keefer, R B Belshe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complexC Y Wang, L S Sawyer, K K Murthy, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|December 1, 1989
Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1K P Anderson, C Lucas, C V Hanson, et al.
Journal of Virology|May 1, 1990
Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animalsS Sutjipto, N C Pedersen, C J Miller, et al.
Asian Pacific Journal of Allergy and Immunology|June 1, 1997
International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, ChinaD Li, B D Forrest, Z Li, et al.
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Prevalence of HTLV-I/II among blood bank donors in ArgentinaM B Bouzas, G R Muchinik, I Zapiola, et al.
The Journal of Infectious Diseases|February 1, 1992
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopesJ J Lipka, I Miyoshi, K G Hadlock, et al.
Asian Pacific Journal of Allergy and Immunology|March 1, 1997
International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, ThailandP Phanuphak, S Teeratakulpixarn, S Sarangbin, et al.
The Journal of Infectious Diseases|August 1, 1991
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and IIJ J Lipka, P Santiago, L Chan, et al.
The Journal of Infectious Diseases|August 1, 1990
Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type IJ J Lipka, K Bui, G R Reyes, et al.
The Journal of Infectious Diseases|February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M C Keefer, R B Belshe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complexC Y Wang, L S Sawyer, K K Murthy, et al.
Pageof 6